Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting

Eric Senbel; Sonia Tropé; Hélène Herman-Demars; Elena Zinovieva; Agnès Courbeyrette; Pierre Clerson; Yann Fardini; René-Marc Flipo

doi:10.2147/ppa.s301010

journal article Open Access Apr 01, 2021

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting

Eric Senbel Sonia Tropé

Hélène Herman-Demars Elena Zinovieva Agnès Courbeyrette Pierre Clerson

Yann Fardini René-Marc Flipo

Patient Preference and Adherence Vol. Volume 15 pp. 751-760 · Informa UK Limited

View at Publisher Save 10.2147/ppa.s301010

Topics

No keywords indexed for this article. Browse by subject →

References

45

[1]

How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy

Peter. C. Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey et al.

Journal of Clinical Medicine 2019 10.3390/jcm8040515

[2]

Kruger Z Rheumatol (2012) 10.1007/s00393-012-1038-0

[3]

O’Dell Arthritis Rheum (2013) 10.1002/art.38012

[4]

Weinblatt Trans Am Clin Climatol Assoc (2013)

[5]

Daien Joint Bone Spine (2018)

[6]

Schiff Ann Rheum Dis (2014) 10.1136/annrheumdis-2014-205228

[7]

Osman Ann Rheum Dis (2001) 10.1136/ard.60.4.432

[8]

Bingham Rheumatology (2003) 10.1093/rheumatology/keg246

[9]

Braun Arthritis Rheum (2008) 10.1002/art.23144

[10]

Pichlmeier Clin Exp Rheumatol (2014)

[11]

Rutkowska-Sak Reumatologia/Rheumatology (2009)

[12]

Chakravarty Rheumatology (2008) 10.1093/rheumatology/kel216a

[13]

Contreras-Yanez Am J Med Sci (2010) 10.1097/maj.0b013e3181e8bcb0

[14]

Scheiman-Elazary J Rheumatol (2016) 10.3899/jrheum.141371

[15]

Mazaud Br J Dermatol (2017) 10.1111/bjd.15377

[16]

Gossec Joint Bone Spine (2019) 10.1016/j.jbspin.2018.08.006

[17]

Pavy Joint Bone Spine (2006) 10.1016/j.jbspin.2006.01.007

[18]

Bello Open Access Rheumatol (2017) 10.2147/oarrr.s131668

[19]

Berlowitz N Engl J Med (2017) 10.1056/nejmoa1611179

[20]

Bress New Engl J Med (2017) 10.1056/nejmsa1616035

[21]

Morisky J Clin Hypertens (2008) 10.1111/j.1751-7176.2008.07572.x

[22]

Morisky J Clin Epidemiol (2011) 10.1016/j.jclinepi.2010.09.002

[23]

van der Heijde Ann Rheum Dis (1990) 10.1136/ard.49.11.916

[24]

Fries Arthritis Rheum (1980) 10.1002/art.1780230202

[25]

Korb‐Savoldelli J Clin Hypertens (2012) 10.1111/j.1751-7176.2012.00634.x

[26]

Gadallah Am J Med Sci (2015) 10.1097/maj.0000000000000376

[27]

Guillemin Arthritis Rheum (1997) 10.1002/1529-0131(199707)40:7<1267::aid-art11>3.0.co;2-l

[28]

Ward Ann Rheum Dis (2015) 10.1136/annrheumdis-2013-205079

[29]

Brown Nat Rev Rheumatol (2016) 10.1038/nrrheum.2016.175

[30]

Herman J Pharm Sci (1989) 10.1002/jps.2600780219

[31]

Lebbe Ann Rheum Dis (1994) 10.1136/ard.53.7.475

[32]

Hoekstra J Rheumatol (2004)

[33]

Stamp J Rheumatol (2011) 10.3899/jrheum.110481

[34]

Dervieux Rheumatology (2010) 10.1093/rheumatology/keq216

[35]

Dervieux Ann Rheum Dis (2005) 10.1136/ard.2004.033399

[36]

De Cuyper Clin Rheumatol (2016) 10.1007/s10067-016-3182-4

[37]

DiBenedetti Rheumatol Ther (2015) 10.1007/s40744-015-0011-1

[38]

Singh Arthritis Care Res (2016) 10.1002/acr.22783

[39]

Smolen Ann Rheum Dis (2017) 10.1136/annrheumdis-2016-210715

[40]

Viller J Rheumatol (1999)

[41]

Fraenkel Ann Rheum Dis (2018) 10.1136/annrheumdis-2017-212407

[42]

Goodacre Rheumatology (2004) 10.1093/rheumatology/keh116

[43]

Gossec Clin Rheumatol (2018) 10.1007/s10067-018-4172-5

[44]

Pasma Rheumatology (2016) 10.1093/rheumatology/kew247

[45]

Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects

Jim McCambridge, John Witton, Diana R. Elbourne

Journal of Clinical Epidemiology 2014 10.1016/j.jclinepi.2013.08.015

Metrics

17

Citations

45

References

Details

Published: Apr 01, 2021
Vol/Issue: Volume 15
Pages: 751-760
License: View

Authors

Medical Department, Nordic Pharma, Paris, France

E

Elena Zinovieva

Medical Department, Nordic Pharma, Paris, France

Orgamétrie Biostatistiques Roubaix France

Cite This Article

Eric Senbel, Sonia Tropé, Hélène Herman-Demars, et al. (2021). Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting. Patient Preference and Adherence, Volume 15, 751-760. https://doi.org/10.2147/ppa.s301010

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting

You May Also Like